|
KIAA0664P3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.574000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.016200E-03 |
| Normal-vs-Stage2 |
2.981600E-01 |
| Normal-vs-Stage3 |
3.392800E-01 |
| Normal-vs-Stage4 |
9.499600E-03 |
| Stage1-vs-Stage2 |
6.928400E-01 |
| Stage1-vs-Stage3 |
3.143900E-03 |
| Stage1-vs-Stage4 |
3.08469999998895E-06 |
| Stage2-vs-Stage3 |
1.040160E-01 |
| Stage2-vs-Stage4 |
1.212210E-02 |
| Stage3-vs-Stage4 |
1.745560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.657200E-01 |
| Normal-vs-AfricanAmerican |
6.154000E-02 |
| Normal-vs-Asian |
2.137200E-01 |
| Caucasian-vs-AfricanAmerican |
8.586300E-02 |
| Caucasian-vs-Asian |
2.284800E-01 |
| AfricanAmerican-vs-Asian |
6.213400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.651600E-01 |
| Normal-vs-Female |
2.721000E-03 |
| Male-vs-Female |
1.353350E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.463000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.859800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.165000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.997000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.530100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.303600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.331840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.587800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.337600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.572200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.799400E-03 |
| Normal-vs-Grade 2 |
3.040300E-02 |
| Normal-vs-Grade 3 |
4.979800E-01 |
| Normal-vs-Grade 4 |
2.33159999996069E-06 |
| Grade 1-vs-Grade 2 |
6.963900E-02 |
| Grade 1-vs-Grade 3 |
1.949760E-02 |
| Grade 1-vs-Grade 4 |
3.51590000446933E-08 |
| Grade 2-vs-Grade 3 |
1.784180E-01 |
| Grade 2-vs-Grade 4 |
7.06629976754414E-10 |
| Grade 3-vs-Grade 4 |
7.44890000015097E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.4916999996627E-07 |
| Normal-vs-ccB subtype |
2.964600E-04 |
| ccA subtype-vs-ccB subtype |
1.62625468647093E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.613630E-01 |
| Normal-vs-N1 |
1.8012999980499E-08 |
| N0-vs-N1 |
2.33470021093751E-10 |
|
|
